Articles tagged with Cancer Patients
The Jess and Mildred Fisher Center for Familial Cancer will expand clinical and research programs at Lombardi Comprehensive Cancer Center, providing automated cancer risk assessment and genetic predisposition research. The center also endows the Cecilia F. Rudman Arts and Humanities Program Fund, enhancing arts therapy and patient care.
A new study found that over half of men with lower-risk prostate cancer received aggressive treatment, despite active surveillance being a viable option. Men under 55 were more likely to receive surgery, while those aged 70-74 were more likely to receive radiation.
A new study suggests that low-risk prostate cancer patients are being overtreated with aggressive therapies such as radiation and surgery. Waiting for treatment to be necessary may improve patient outcomes and reduce unnecessary harm.
A new study reveals that racial disparities in cancer outcomes may be attributed to problems in doctor-patient communication. African-American patients tend to receive less information and are less actively involved in their medical decisions, leading to potential negative impacts on care.
A new study suggests that post-transplant lymphoproliferative disorder (PTLD) arises when immune cells called scout cells become weakened, allowing the Epstein-Barr virus to cause cancer. The study identifies a mechanism that may explain why some patients develop PTLD and others don't.
A new study suggests that women with endometrial cancer should be screened for inherited Lynch syndrome mutations, which are associated with a high risk of several cancers. The study found that 1.8% of newly diagnosed endometrial cancer patients have these mutations, highlighting the importance of genetic screening and early detection.
The study found that CAD increased cancer detection by 13.3% in screening-detected cancers and 14.2% for ductal carcinoma in situ (DCIS).CAD also improved recall rates and reduced false negatives, with the greatest impact on symptomatic patients.
A new study finds that hospice enrollment rates vary more by health center than individual patient characteristics. Additionally, a meta-analysis suggests that high processed meat consumption is associated with an increased risk of stomach cancer, while another study identifies a potential target for leukemia treatment and notes the pe...
Researchers found that combining chemotherapy with radiation therapy after surgery significantly improves survival rates for patients with advanced pancreatic cancer. The study showed a median survival time of 18.3 months, compared to the national average of 11 months.
A study found that cancer patients who used information services and online support groups experienced improved learning outcomes. The analysis revealed that interactive services also predicted improved learning outcomes, while interacting with an online expert did not contribute to benefits.
A meta-analysis of 59 trials found little evidence that diet affects cancer survival or prognosis, while a study on garlic and vitamin supplements showed no benefit in reducing precancerous gastric lesions to cancer. Long-term use of vitamins and garlic supplements had no effect on gastric cancer incidence.
Researchers have developed a non-invasive method to detect bladder cancer using DNA found in urine, while a study suggests high pesticide exposure increases the risk of liver cancer. Additionally, a growth factor has been found to inhibit lung tumor metastasis by stopping blood vessel growth and breaking down specific proteins.
Using mass spectrometry, researchers identified three activating mutations of the tyrosine kinase JAK3 in AML cells, leading to a potential new treatment target. The study's fast and affordable approach could help analyze cancer cells for mutations in just weeks.
Stanford University researchers developed a 3D PET/CT imaging technique that provides a visual navigation of organs, allowing for better detection and characterization of cancer. The technology has potential for presurgical visualization, guiding biopsies and identifying tumor 'hot spots', enabling more precise diagnosis and treatment.
Researchers at the University of Pennsylvania School of Medicine used molecular imaging techniques to discover small molecule compounds that can restore normal p53 function in cancer cells, killing human tumor cells. The findings emphasize the growing role of imaging technology in individualized cancer treatments.
A new study published in The Lancet Oncology reveals that boost radiotherapy is an effective strategy to prevent cancer recurrence in young women with ductal carcinoma in situ (DCIS). Researchers found that the most effective approach was radiotherapy with a boost, which significantly reduced the risk of cancer return.
The publication of consensus recommendations for FDG PET usage is expected to reduce variability in clinical trials, leading to shorter trials and improved treatment outcomes. The guidelines provide a valuable reference for incorporating PET into clinical trials and promoting drug development.
Researchers at Saint Louis University School of Medicine found that heated blankets can significantly reduce false-positives in cancer scans caused by brown adipose tissue. The blankets reduced the uptake of tracer by 62%, compared to 30% with traditional drugs.
A new approach to lymph node examination, called targeted lymph node examination, has been shown to improve staging of colon cancer. This technique uses blue dye to identify the sentinel node, which is the first node to receive lymphatic drainage from a primary tumor site.
The new technology allows for standardized, electronic reports after surgeries, improving data analysis and patient outcomes. It has been adopted by the Alberta Cancer Board and other health regions, tracking surgical effectiveness and resource allocation.
A recent study found that major pancreatic cancer surgery can be successfully performed on patients in their 80s, 90s, and older with comparable five-year survival rates to the general population. This challenges common misconceptions about the suitability of elderly patients for such surgery.
A pilot study found that folic acid supplementation significantly increased mean folate levels and decreased homocysteine levels, leading to complete resolution of leucoplakia lesions in 28% of patients. The results suggest folate may effectively reduce cancer progression risk, especially in those with hypofolatemia.
The Vera Bradley Foundation has donated $6.8M to the IU Breast Cancer Research Program, supporting groundbreaking research and improving treatment outcomes for patients. The gift is the foundation's 13th major donation to IU School of Medicine and marks a continued commitment to finding a cure for breast cancer.
A study published in the Journal of the National Cancer Institute found that screening for lung cancer can lead to overdiagnosis, resulting in unnecessary treatment and harm. The study suggests that mass screening may not be beneficial for public health due to the potential for overdiagnosis bias.
A randomized, controlled study found that exercise reduced cancer-related fatigue and improved strength during radiation treatment, with participants taking at least 12,000 steps per day. The study showed that moderate physical activity resulted in significant improvements in aerobic capacity and reduced fatigue.
Researchers have introduced a new technique combining SPECT and spiral CT for improved bone scanning, shortening diagnostic time and clarifying findings. The technology has been shown to enhance the specificity of bone scintigraphy and reduce CT radiation exposure.
Researchers have discovered a new biomarker, ICAM, that can predict lung cancer treatment response and survival. Patients with low levels of ICAM had a higher response rate to treatment and significantly better overall survival rates.
Research highlights continued health risks following surgery, particularly for patients with serious underlying diseases. By understanding the mechanisms of inflammation and adopting strategies such as minimizing surgical incisions and pre-surgery medication, healthcare teams can reduce these risks.
A study found that patients with advanced liver, gallbladder, and bile duct cancers who developed a skin rash while treated with lapatinib lived for an average of 10 months, compared to five months for those without the rash. The treatment was well-tolerated, with two patients experiencing partial responses to treatment.
A new combination therapy after surgery has improved survival rates for pancreatic cancer patients by 50%, increasing median survival from 16.9 to 20.6 months. The study found significant benefits for patients with pancreatic head adenocarcinoma, a type of cancer that affects the pancreas.
A new study confirms that, despite an increase in hospice care, many terminally ill cancer patients continue to receive aggressive treatment in the last days of life. The study found that while hospice use increased steadily over time, it was often not used for symptom relief and building relationships.
A five-year update from the IRIS Study Group shows excellent results for people with Chronic Myelogenous Leukemia (CML) treated with Gleevec, a targeted cancer therapy. Overall survival rates reach 89% at five years, with fewer than 1% of patients progressing to accelerated or blast crisis phases.
The ASCO and ESMO have released a consensus statement outlining 10 essential components of quality cancer care, aiming to address inequalities in healthcare systems worldwide. The document highlights the importance of informed consent, multidisciplinary care teams, and access to innovative treatments for patients diagnosed with cancer.
A randomized trial involving 250 patients with advanced prostate cancer found that high-dose calcitriol (DN-101) significantly reduced venous and arterial thromboses compared to a placebo. This unexpected benefit offers an avenue of investigation for improved safety in various cancers.
A study in Queensland, Australia found that Indigenous patients had lower survival rates and fewer cases of early-stage cancer compared to non-Indigenous patients. The researchers highlight the need for holistic and culturally respectful approaches to address these disparities.
Long-term cancer survivors experience ongoing concerns about cancer recurrence and treatment side effects, affecting their mental health. Research found that these worries are linked to depression and anxiety, with varying levels of concern across different types of cancer.
A study analyzed data from over 35,975 individuals who underwent colonoscopy without detecting colorectal neoplasia. The results showed a significant decrease in colorectal cancer incidence at 6 months (31%) and persisted for more than 10 years. A negative colonoscopy was associated with a lower risk of developing CRC.
Research suggests that diabetes may be a marker of early pancreatic cancer, with studies showing increased rates of colon, pancreatic, and esophageal cancers in patients with diabetes. Additionally, women with type 2 diabetes are at higher risk of developing colorectal adenomas and advanced adenoma.
A new study from the University of Michigan finds that patients often struggle to access reliable medical information online. Librarians play a crucial role in helping patients find quality resources, providing expertise and accessing specialized databases not available to the general public.
A new blood test measures the rate of nicotine metabolism to predict quitting success, distinguishing smokers who need higher doses of nicotine or alternative therapies. The study used saliva samples from 480 smokers and found a link between rapid metabolism and increased craving.
The IU Cancer Center will attract top-tier scientists and physicians with the gift, enhancing its national reputation as a leader in cancer research and patient care. The center's research and clinical programs are expanding, and partnerships are increasing to achieve goals.
The NYU algorithm uses Bayesian statistics to pinpoint tumor suppressor genes in cancer genomes. By analyzing segmental deletions and spatial relations, the algorithm detects genes that were previously unknown or overlooked.
A study found that lobular breast cancer (ILC) and ductal breast cancer (IDC) have similar success rates for breast-conserving therapy. ILC patients had larger tumors, but the success rate did not differ between groups.
Researchers evaluated 92 patients with bladder cancers using MDCT and found 87 tumors, regardless of whether contrast was used. They also discovered that new CT technology can scan rapidly enough to evaluate the bladder fully, potentially obviating the need for invasive cystoscopy.
Researchers have identified a biological marker that predicts persistent fatigue in breast cancer survivors, attributed to inflammation. The biomarker combines immune response elements, including interleukin-6 receptor and T cells with CD69 protein.
Patients who never smoked showed improved response to chemotherapy and longer survival rates compared to former and current smokers. The finding may be attributed to non-smokers having less genetic damage and better preserved lung function.
A study by Wake Forest Baptist suggests that all tumors spreading from the appendix are cancer, regardless of microscopic appearance. Patients with low-grade variant have high survival rates when treated with surgery and chemotherapy.
Researchers argue that surgery is most effective approach in many patients, improving five-year survival rates compared to chemotherapy and radiation. The study found that en bloc esophagectomy results in fewer cancer deaths than transhiatal resection.
The study reveals high molecular heterogeneity in multiple myeloma, with new recurrent amplifications and deletions pointing to yet-to-be-discovered oncogenes and tumor suppressor genes. These findings define new disease subgroups with distinct clinical outcomes and potential therapeutic implications.
Researchers have identified a potential new treatment for malignant gliomas using bortezomib, which targets the NF-kB pathway to induce cell death. This discovery builds on previous studies showing that selective estrogen receptor modulators (SERMs) can also induce cell death in brain cancers.
Researchers identify mutation in JAK2 signaling pathway, allowing cells to bypass normal red blood-cell production process. This discovery could lead to the development of targeted treatments that improve treatment outcomes for patients with PV disease.
Researchers discovered four protein biomarkers that can predict death from colorectal cancer independent of stage or location. A micro-RNA signature also predicts colon cancer development by regulating gene expression and cellular pathways.
A large clinical trial of low-dose isotretinoin in early-stage head and neck cancer patients found no reduction in second primary tumors or improved survival. Current smokers had increased rates of second primary tumors and death, highlighting the importance of smoking cessation.
Researchers have developed novel diagnostic tests for lung cancer using airway gene expression assays, which identified three times as many early-stage cancers as conventional bronchoscopy. Genetic signatures from epithelial cells complement clinical results to diagnose 95% of patients with lung cancer.
Panitumumab significantly improves progression-free survival and disease control in patients with mCRC, with a median duration of response of 17 weeks. The treatment was well-tolerated, with few major adverse reactions.
Researchers found a significant increase in cancer risk among first-degree relatives of lung cancer patients, particularly young onset cancers. The study's findings suggest that genetic factors play a crucial role in the development of lung cancer and other types of cancer.
A new study comparing healthcare systems in Australia and the US found that young patients are more likely to survive cancer in Australia due to universal health insurance. The US system, which relies on private insurance, leads to a higher mortality rate among teenagers and young adults.
Experts warn that doctors must discuss future fertility with young cancer patients to provide truly informed consent. Current data indicate room for improvement in fertility counselling, with only 34% of patients receiving pre-treatment advice.
The UK's first Professor of Teenage and Young Adult Cancer emphasizes the need for improved communication and coordination among pediatricians, oncologists, and other healthcare professionals. Currently, TYA cancer patients often receive sub-standard treatment due to fragmented care.
A lack of specialist training for nurses is failing adolescent cancer patients, according to a nurse manager at the Manchester Teenage Cancer Trust Unit. The unique needs of teenagers and young adults with cancer require expertise in disease management, symptom control, and psychosocial issues.